C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.720
-0.030 (-1.09%)
At close: Mar 13, 2026, 4:00 PM EDT
2.747
+0.027 (1.01%)
After-hours: Mar 13, 2026, 7:32 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $265.41 million as of March 13, 2026. Its market cap has increased by 41.89% in one year.
Market Cap
265.41M
Enterprise Value
31.22M
1-Year Change
41.89%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $265.41M, a decrease of -65.65%. That is a compound annual growth rate of -17.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 268.34M | 44.97% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 305.26M |
| Protara Therapeutics | 302.87M |
| AC Immune | 302.77M |
| Palisade Bio | 298.01M |
| Aldeyra Therapeutics | 297.30M |
| Context Therapeutics | 291.26M |
| Camp4 Therapeutics | 290.75M |
| Voyager Therapeutics | 289.06M |